Right Ventricular Function in Patients With Left Ventricular Assist Device Support by Pulsatile Polvad MEV and Continuous-Flow Pumps Heartware and Heartmate II

被引:0
作者
Nadziakiewicz, P. [1 ]
Borkowski, J. [1 ]
Szygula-Jurkiewicz, B. [2 ]
Niklewski, T. [3 ]
Pacholewicz, J. [3 ]
Zakliczynski, M. [3 ]
Hrapkowic, T. [3 ]
Zennbala, M. [3 ]
机构
[1] Silesian Ctr Heart Dis, Dept Cardiac Anesthesia & Intens Care SUM, Ul Sklodowskiej Curie 9, PL-41800 Zabrze, Poland
[2] Med Univ Silesia, SMDZ Zabrze, Clin Dept Cardiac Anesthesia & Intens Care, Katowice, Poland
[3] Silesian Ctr Heart Dis, Dept Cardiac Surg & Transplantat SUM, Zabrze, Poland
关键词
CLINICAL-EXPERIENCE; IMPLANTATION; FAILURE; DYSFUNCTION;
D O I
10.1016/j.transproceed.2016.01.065
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Left ventricular assist device (LVAD) support is increasingly used in patients with heart failure. The right ventricle (RV) plays a main role in LVAD support. Little is known about the effects of pulsatile Polvad MEV devices or continuouseconds flow pumps on RV function. We compared hemodynamic parameters of RV in patients after implantation of Polvad MEV (PM) and Heartware (HW) or Heartmate II (HMII) LVADs. Methods. Forty-four patients were retrospectively reviewed after implantation of PM (group P; n = 24 [21 M, 3 F]) or HW or HMII (group C; n = 20 [20 M, 0 F]) LVADs from April 2007 to February 2014. Hemodynamic data mean pulmonary pressure (mPAP), central venous pressure (CVP), cardiac output (CO), and cardiac index (CI) were collected before surgery, after surgery, and every 2 hours in the intensive care unit, with the time points numbered from 1 to 120. Right ventricular work (RVW) was calculated according to the equation: RCW = CO x (mPAP - CVP) x 0.0144 (g.m). Results. Baseline characteristic of the patients were similar. mPAP values were similar between groups. CVP values were higher in group P, significantly at time points 5 and 7-33. CO values were higher in group C, significantly from point 3 and almost all the time to point 43. CI reached significance at point 9, 12-14, 16-19, and 30-41. RCW was higher in group P before implantation. Post-implantation RCW values were higher in group C, significantly at time points 19, 20, 32-34, 51-53, and 55-57. Conclusions. Continuous-flow pumps more effectively optimize RV function than pulsatile LVADs, which can result in more effective prevention of RV failure or insuffiency in that group.
引用
收藏
页码:1786 / 1790
页数:5
相关论文
共 21 条
  • [11] Right ventricular failure after LVAD implantation: Prevention and treatment
    Meineri, Massimiliano
    Van Rensburg, Adriaan E.
    Vegas, Annette
    [J]. BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY, 2012, 26 (02) : 217 - 229
  • [12] Predictors of severe right ventricular failure after Implantable left ventricular assist device insertion: Analysis of 245 patients
    Ochiai, Y
    McCarthy, PM
    Smedira, NG
    Banbury, MK
    Navia, JL
    Feng, JY
    Hsu, AP
    Yeager, ML
    Buda, T
    Hoercher, KJ
    Howard, MW
    Takagaki, M
    Doi, K
    Fukamachi, K
    [J]. CIRCULATION, 2002, 106 (13) : I198 - I202
  • [13] Right ventricular performance during left ventricular unloading conditions: The contribution of the right ventricular free wall
    Omoto, T
    Tanabe, H
    LaRia, PJ
    Guererro, J
    Vlahakes, GJ
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2002, 50 (01) : 16 - 20
  • [14] Left ventricular assist devices as destination therapy: A new look at survival
    Park, SJ
    Tector, A
    Piccioni, W
    Raines, E
    Gelijns, A
    Moskowitz, A
    Rose, E
    Holman, W
    Furukawa, S
    Frazier, OH
    Dembitsky, W
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 129 (01) : 9 - 17
  • [15] Right heart dysfunction after left ventricular assist device implantation: A comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices
    Patel, Nishant D.
    Weiss, Eric S.
    Schaffer, Justin
    Ullrich, Susan L.
    Rivard, Dennis C.
    Shah, Ashish S.
    Russell, Stuart D.
    Conte, John V.
    [J]. ANNALS OF THORACIC SURGERY, 2008, 86 (03) : 832 - 840
  • [16] 8 YEARS EXPERIENCE WITH BRIDGING TO CARDIAC TRANSPLANTATION
    PENNINGTON, DG
    MCBRIDE, LR
    PEIGH, PS
    MILLER, LW
    SWARTZ, MT
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1994, 107 (02) : 472 - 481
  • [18] Inhaled nitric oxide after left ventricular assist device implantation: A prospective, randomized, double-blind, multicenter, placebo-controlled trial
    Potapov, Evgenij
    Meyer, Dan
    Swaminathan, Madhav
    Ramsay, Michael
    El Banayosy, Aly
    Diehl, Christoph
    Veynovich, Bryan
    Gregoric, Igor D.
    Kukucka, Marian
    Gromann, Tom W.
    Marczin, Nandor
    Chittuluru, Kanti
    Baldassarre, James S.
    Zucker, Mark J.
    Hetzer, Roland
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (08) : 870 - 878
  • [19] Long-term use of a left ventricular assist device for end-stage heart failure
    Rose, EA
    Gelijns, AC
    Moskowitz, AJ
    Heitjan, DF
    Stevenson, LW
    Dembitsky, W
    Long, JW
    Ascheim, DD
    Tierney, AR
    Levitan, RG
    Watson, JT
    Meier, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20) : 1435 - 1443
  • [20] Ventricular Assist Devices Today and Tomorrow
    Thunberg, Christopher A.
    Gaitan, Brantley Dollar
    Arabia, Francisco A.
    Cole, Daniel J.
    Grigore, Alina M.
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2010, 24 (04) : 656 - 680